SCANDION ONC (Germany) Performance
| 8VY Stock | EUR 0.01 0.0002 3.33% |
The firm owns a Beta (Systematic Risk) of -0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning SCANDION ONC are expected to decrease at a much lower rate. During the bear market, SCANDION ONC is likely to outperform the market. At this point, SCANDION ONC DK has a negative expected return of -1.06%. Please make sure to validate SCANDION ONC's coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if SCANDION ONC DK performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SCANDION ONC DK 0735 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
SCANDION |
SCANDION ONC Relative Risk vs. Return Landscape
If you would invest 1.26 in SCANDION ONC DK 0735 on August 26, 2024 and sell it today you would lose (0.68) from holding SCANDION ONC DK 0735 or give up 53.97% of portfolio value over 90 days. SCANDION ONC DK 0735 is currently producing negative expected returns and takes up 4.5428% volatility of returns over 90 trading days. Put another way, 40% of traded stocks are less volatile than SCANDION, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SCANDION ONC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SCANDION ONC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCANDION ONC DK 0735, and traders can use it to determine the average amount a SCANDION ONC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2341
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 8VY |
Estimated Market Risk
| 4.54 actual daily | 40 60% of assets are more volatile |
Expected Return
| -1.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SCANDION ONC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCANDION ONC by adding SCANDION ONC to a well-diversified portfolio.
SCANDION ONC Fundamentals Growth
SCANDION Stock prices reflect investors' perceptions of the future prospects and financial health of SCANDION ONC, and SCANDION ONC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SCANDION Stock performance.
| Return On Equity | -0.74 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | 473.28 % | |||
| Shares Outstanding | 40.71 M | |||
| Revenue | (169 K) | |||
| EBITDA | (79.71 M) | |||
| Cash And Equivalents | 145.22 M | |||
| Cash Per Share | 4.52 X | |||
| Book Value Per Share | 2.10 X | |||
| Cash Flow From Operations | (19.55 M) | |||
| Earnings Per Share | (0.23) X | |||
About SCANDION ONC Performance
By analyzing SCANDION ONC's fundamental ratios, stakeholders can gain valuable insights into SCANDION ONC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCANDION ONC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCANDION ONC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Scandion Oncology AS, a biotechnology company, develops drugs for the treatment of chemotherapy resistance in cancer patients. The company was founded in 2017 and is based in Copenhagen, Denmark. SCANDION ONC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.Things to note about SCANDION ONC DK performance evaluation
Checking the ongoing alerts about SCANDION ONC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCANDION ONC DK help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SCANDION ONC DK generated a negative expected return over the last 90 days | |
| SCANDION ONC DK has some characteristics of a very speculative penny stock | |
| SCANDION ONC DK has high historical volatility and very poor performance | |
| SCANDION ONC DK has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (21.25 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| SCANDION ONC DK 0735 has accumulated about 145.22 M in cash with (19.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing SCANDION ONC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCANDION ONC's stock is overvalued or undervalued compared to its peers.
- Examining SCANDION ONC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SCANDION ONC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCANDION ONC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SCANDION ONC's stock. These opinions can provide insight into SCANDION ONC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SCANDION Stock analysis
When running SCANDION ONC's price analysis, check to measure SCANDION ONC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDION ONC is operating at the current time. Most of SCANDION ONC's value examination focuses on studying past and present price action to predict the probability of SCANDION ONC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDION ONC's price. Additionally, you may evaluate how the addition of SCANDION ONC to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets |